• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Rpglife Share Price

    Rpg Life Sciences Share PriceRPG Life Sciences

    Small Cap 4.1k Result
    ₹1,365.95
    -13.8 (-1%)
    As on 12 December, 2023 | 01:13 BSE: 532983 NSE: RPGLIFEISIN: INE105J01010

    Rpg Life Sciences Performance

    Day Range

    • Low 1,362.00
    • High 1,388.75
    ₹ 1,365.95

    52 Week Range

    • Low 645.50
    • High 1,505.00
    ₹ 1,365.95
    • Open Price1,388.75
    • Previous Close1,379.75
    • Volume6126

    Start SIP in RPG Life Sciences

    Start SIP

    Rpg Life Sciences Share Price

    • Over 1 Month -6.34%
    • Over 3 Month 8.67%
    • Over 6 Month 48.81%
    • Over 1 Year 53.78%

    Rpg Life Sciences Key Statistics

    P/E Ratio 29.2
    PEG Ratio 1
    Market Cap Cr 2,259
    Price to Book Ratio 7.3
    EPS 41.2
    Dividend 0.9
    Relative Strength Index 43.94
    Money Flow Index 32.56
    MACD Signal -0.14
    Average True Range 46.55

    Rpg Life Sciences Investment Rating

    • Master Rating:

    • R P G Life Sciences has an operating revenue of Rs. 550.45 Cr. on a trailing 12-month basis. An annual revenue growth of 17% is outstanding, Pre-tax margin of 18% is great, ROE of 21% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 32% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 8% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 95 which is a GREAT score indicating consistency in earnings, a RS Rating of 72 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 75 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    RPG Life Sciences Financials
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 154148118131135129104
    Operating Expenses Qtr Cr 11611610310110510190
    Operating Profit Qtr Cr 37321629302814
    Depreciation Qtr Cr 4444444
    Interest Qtr Cr 0000000
    Tax Qtr Cr 9837773
    Net Profit Qtr Cr 2622101920188
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 518443
    Operating Expenses Annual Cr 410354
    Operating Profit Annual in Cr 10386
    Depreciation Cr 1616
    Interest Annual Cr 01
    Tax Annual Cr 2422
    Net Profit Annual Cr 6851
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 9165
    Cash from Investing Activity Annual Cr -106-35
    Cash from Financing Annual Activity Cr -17-14
    Net Cash Flow Annual Cr -3217
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 308256
    Fixed Assets Annual Cr 150135
    Total Non Current Assets Annual Cr 155138
    Total Current Assets Annual Cr 264207
    Total Assets Annual Cr 419345
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 186155
    ROE Annual % 2220
    ROCE Annual % 2928
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2120
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr
    Operating Expenses Qtr Cr
    Operating Profit Qtr Cr
    Depreciation Qtr Cr
    Interest Qtr Cr
    Tax Qtr Cr
    Net Profit Qtr Cr
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr
    Operating Expenses Annual Cr
    Operating Profit Annual in Cr
    Depreciation Cr
    Interest Annual Cr
    Tax Annual Cr
    Net Profit Annual Cr
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr
    Cash from Investing Activity Annual Cr
    Cash from Financing Annual Activity Cr
    Net Cash Flow Annual Cr
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr
    Fixed Assets Annual Cr
    Total Non Current Assets Annual Cr
    Total Current Assets Annual Cr
    Total Assets Annual Cr
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs
    ROE Annual %
    ROCE Annual %
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin %
    Invest in Rpg Life Sciences

    Rpg Life Sciences Technicals

    EMA & SMA

    Current Price
    ₹1,365.95
    -13.8 (-1%)
    pointer
    • Bullish Moving Average
    • ___
    • 5
    • Bearish Moving Average
    • ___
    • 11
    • 20 Day
    • ₹1,396.37
    • 50 Day
    • ₹1,368.75
    • 100 Day
    • ₹1,274.18
    • 200 Day
    • ₹1,126.05
    • 20 Day
    • ₹1,412.02
    • 50 Day
    • ₹1,384.72
    • 100 Day
    • ₹1,278.29
    • 200 Day
    • ₹1,047.04

    Rpg Life Sciences Resistance and Support

    PIVOT
    ₹1,372.24
    Resistance
    First Resistance 1,382.47
    Second Resistance 1,398.98
    Third Resistance 1,409.22
    RSI 43.94
    MFI 32.56
    MACD Single Line -0.14
    MACD -8.81
    Support
    First Resistance 1,355.72
    Second Resistance 1,345.48
    Third Resistance 1,328.97

    Rpg Life Sciences Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 7,286 441,532 60.6
    Week 17,046 913,815 53.61
    1 Month 21,705 1,004,069 46.26
    6 Month 48,330 2,078,173 43

    Rpg Life Sciences Result Highlights

    RPG Life Sciences Synopsis

    NSE-Medical-Diversified

    Rpg Life Sciences is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 512.81 Cr. and Equity Capital is Rs. 13.23 Cr. for the Year ended 31/03/2023. RPG Life Sciences Ltd. is a Public Limited Listed company incorporated on 29/03/2007 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24232MH2007PLC169354 and registration number is 169354.
    Market Cap 2,261
    Sales 550
    Shares in Float 0.45
    No of funds 32
    Yield 0.87
    Book Value 7.42
    U/D Vol ratio 1.7
    LTDebt / Equity
    Alpha 0.17
    Beta 0.8

    RPG Life Sciences

    Owner NameSep-23Jun-23Mar-23Dec-22
    Promoters 72.81%72.81%72.81%72.61%
    Mutual Funds 0.82%
    Insurance Companies 0.51%
    Foreign Portfolio Investors 0.46%0.33%0.38%0.25%
    Financial Institutions/ Banks 0.01%0.01%0.01%
    Individual Investors 18.41%19.45%19.91%20.26%
    Others 6.98%7.4%6.9%6.87%

    RPG Life Sciences Management

    Name Designation
    Mr. Harsh V Goenka Chairman
    Mr. Yugal Sikri Managing Director
    Mr. Rajat Bhargava Non Executive Director
    Mr. Sachin Nandgaonkar Non Executive Director
    Mr. Manoj K Maheshwari Independent Director
    Mr. Narendra Ambwani Independent Director
    Ms. Zahabiya Khorakiwala Independent Director
    Mr. Bhaskar Iyer Independent Director
    Dr. Lalit S Kanodia Independent Director
    Mr. Mahesh S Gupta Independent Director

    Rpg Life Sciences Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Rpg Life Sciences Corporate Action

    Date Purpose Remarks
    2023-10-18 Quarterly Results
    2023-07-28 Quarterly Results
    2023-04-28 Audited Results & Final Dividend
    2023-02-01 Quarterly Results
    2022-10-17 Quarterly Results
    Date Purpose Remarks
    2023-07-21 FINAL Rs.12.00 per share(150%)Final Dividend
    2022-07-15 FINAL Rs.9.60 per share(120%)Final Dividend
    2021-08-17 FINAL Rs.7.20 per share(90%)Dividend

    RPG Life Sciences MF Shareholding

    Name Amount(cr)
    Mirae Asset Multicap Fund Regular Growth 1,731
    Motilal Oswal S&P BSE Healthcare ETF 8

    RPG Life Sciences FAQs

    What is Share Price of RPG Life Sciences ?

    RPG Life Sciences share price is ₹1,365 As on 12 December, 2023 | 00:59

    What is the Market Cap of RPG Life Sciences ?

    The Market Cap of RPG Life Sciences is ₹2259.1 Cr As on 12 December, 2023 | 00:59

    What is the P/E ratio of RPG Life Sciences ?

    The P/E ratio of RPG Life Sciences is 29.2 As on 12 December, 2023 | 00:59

    What is the PB ratio of RPG Life Sciences ?

    The PB ratio of RPG Life Sciences is 7.3 As on 12 December, 2023 | 00:59

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.